840 related articles for article (PubMed ID: 28213165)
21. Recombinant covalently closed circular hepatitis B virus DNA induces prolonged viral persistence in immunocompetent mice.
Qi Z; Li G; Hu H; Yang C; Zhang X; Leng Q; Xie Y; Yu D; Zhang X; Gao Y; Lan K; Deng Q
J Virol; 2014 Jul; 88(14):8045-56. PubMed ID: 24807718
[TBL] [Abstract][Full Text] [Related]
22. The recombined cccDNA produced using minicircle technology mimicked HBV genome in structure and function closely.
Guo X; Chen P; Hou X; Xu W; Wang D; Wang TY; Zhang L; Zheng G; Gao ZL; He CY; Zhou B; Chen ZY
Sci Rep; 2016 May; 6():25552. PubMed ID: 27174254
[TBL] [Abstract][Full Text] [Related]
23. A Novel Mouse Model Harboring Hepatitis B Virus Covalently Closed Circular DNA.
Xu Z; Zhao L; Zhong Y; Zhu C; Zhao K; Teng Y; Cheng X; Chen Q; Xia Y
Cell Mol Gastroenterol Hepatol; 2022; 13(4):1001-1017. PubMed ID: 34896285
[TBL] [Abstract][Full Text] [Related]
24. Inactivation of hepatitis B virus replication in cultured cells and in vivo with engineered transcription activator-like effector nucleases.
Bloom K; Ely A; Mussolino C; Cathomen T; Arbuthnot P
Mol Ther; 2013 Oct; 21(10):1889-97. PubMed ID: 23883864
[TBL] [Abstract][Full Text] [Related]
25. Cellular DNA Topoisomerases Are Required for the Synthesis of Hepatitis B Virus Covalently Closed Circular DNA.
Sheraz M; Cheng J; Tang L; Chang J; Guo JT
J Virol; 2019 Jun; 93(11):. PubMed ID: 30867306
[TBL] [Abstract][Full Text] [Related]
26. DNA Polymerase κ Is a Key Cellular Factor for the Formation of Covalently Closed Circular DNA of Hepatitis B Virus.
Qi Y; Gao Z; Xu G; Peng B; Liu C; Yan H; Yao Q; Sun G; Liu Y; Tang D; Song Z; He W; Sun Y; Guo JT; Li W
PLoS Pathog; 2016 Oct; 12(10):e1005893. PubMed ID: 27783675
[TBL] [Abstract][Full Text] [Related]
27. Transcription of hepatitis B virus covalently closed circular DNA is regulated by CpG methylation during chronic infection.
Zhang Y; Mao R; Yan R; Cai D; Zhang Y; Zhu H; Kang Y; Liu H; Wang J; Qin Y; Huang Y; Guo H; Zhang J
PLoS One; 2014; 9(10):e110442. PubMed ID: 25337821
[TBL] [Abstract][Full Text] [Related]
28. DNA Polymerase alpha is essential for intracellular amplification of hepatitis B virus covalently closed circular DNA.
Tang L; Sheraz M; McGrane M; Chang J; Guo JT
PLoS Pathog; 2019 Apr; 15(4):e1007742. PubMed ID: 31026293
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of hepatitis B virus cccDNA by siRNA in transgenic mice.
Li G; Jiang G; Lu J; Chen S; Cui L; Jiao J; Wang Y
Cell Biochem Biophys; 2014 Jul; 69(3):649-54. PubMed ID: 24569930
[TBL] [Abstract][Full Text] [Related]
30. Nonproductive Hepatitis B Virus Covalently Closed Circular DNA Generates HBx-Related Transcripts from the HBx/Enhancer I Region and Acquires Reactivation by Superinfection in Single Cells.
Peng B; Jing Z; Zhou Z; Sun Y; Guo G; Tan Z; Diao Y; Yao Q; Ping Y; Li X; Ren T; Li B; Li W
J Virol; 2023 Jan; 97(1):e0171722. PubMed ID: 36475867
[TBL] [Abstract][Full Text] [Related]
31. Parvulin 14 and Parvulin 17 Bind to HBx and cccDNA and Upregulate Hepatitis B Virus Replication from cccDNA to Virion in an HBx-Dependent Manner.
Saeed U; Kim J; Piracha ZZ; Kwon H; Jung J; Chwae YJ; Park S; Shin HJ; Kim K
J Virol; 2019 Mar; 93(6):. PubMed ID: 30567987
[TBL] [Abstract][Full Text] [Related]
32. In vivo proliferation of hepadnavirus-infected hepatocytes induces loss of covalently closed circular DNA in mice.
Lutgehetmann M; Volz T; Köpke A; Broja T; Tigges E; Lohse AW; Fuchs E; Murray JM; Petersen J; Dandri M
Hepatology; 2010 Jul; 52(1):16-24. PubMed ID: 20578126
[TBL] [Abstract][Full Text] [Related]
33. Attacking hepatitis B virus cccDNA--The holy grail to hepatitis B cure.
Lucifora J; Protzer U
J Hepatol; 2016 Apr; 64(1 Suppl):S41-S48. PubMed ID: 27084036
[TBL] [Abstract][Full Text] [Related]
34. HBV covalently closed circular DNA minichromosomes in distinct epigenetic transcriptional states differ in their vulnerability to damage.
Wang Y; Li Y; Zai W; Hu K; Zhu Y; Deng Q; Wu M; Li Y; Chen J; Yuan Z
Hepatology; 2022 May; 75(5):1275-1288. PubMed ID: 34779008
[TBL] [Abstract][Full Text] [Related]
35. Novel therapeutic approaches for hepatitis B virus covalently closed circular DNA.
Ohno M; Otsuka M; Kishikawa T; Yoshikawa T; Takata A; Koike K
World J Gastroenterol; 2015 Jun; 21(23):7084-8. PubMed ID: 26109795
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of HBV Transcription From cccDNA With Nitazoxanide by Targeting the HBx-DDB1 Interaction.
Sekiba K; Otsuka M; Ohno M; Yamagami M; Kishikawa T; Suzuki T; Ishibashi R; Seimiya T; Tanaka E; Koike K
Cell Mol Gastroenterol Hepatol; 2019; 7(2):297-312. PubMed ID: 30704981
[TBL] [Abstract][Full Text] [Related]
37. The Role of cccDNA in HBV Maintenance.
Allweiss L; Dandri M
Viruses; 2017 Jun; 9(6):. PubMed ID: 28635668
[TBL] [Abstract][Full Text] [Related]
38. Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation.
Cai D; Mills C; Yu W; Yan R; Aldrich CE; Saputelli JR; Mason WS; Xu X; Guo JT; Block TM; Cuconati A; Guo H
Antimicrob Agents Chemother; 2012 Aug; 56(8):4277-88. PubMed ID: 22644022
[TBL] [Abstract][Full Text] [Related]
39. An Alternatively Spliced Sirtuin 2 Isoform 5 Inhibits Hepatitis B Virus Replication from cccDNA by Repressing Epigenetic Modifications Made by Histone Lysine Methyltransferases.
Piracha ZZ; Saeed U; Kim J; Kwon H; Chwae YJ; Lee HW; Lim JH; Park S; Shin HJ; Kim K
J Virol; 2020 Jul; 94(16):. PubMed ID: 32493816
[TBL] [Abstract][Full Text] [Related]
40. Minicircle HBV cccDNA with a Gaussia luciferase reporter for investigating HBV cccDNA biology and developing cccDNA-targeting drugs.
Li F; Cheng L; Murphy CM; Reszka-Blanco NJ; Wu Y; Chi L; Hu J; Su L
Sci Rep; 2016 Nov; 6():36483. PubMed ID: 27819342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
